Christopher M Celano1, Ariana M Albanese, Rachel A Millstein, Carol A Mastromauro, Wei-Jean Chung, Kirsti A Campbell, Sean R Legler, Elyse R Park, Brian C Healy, Linda M Collins, James L Januzzi, Jeff C Huffman. 1. From the Harvard Medical School (Celano, Millstein, Chung, Campbell, Legler, Park, Healy, Januzzi, Huffman); Departments of Psychiatry (Celano, Albanese, Millstein, Mastromauro, Chung, Campbell, Legler, Park, Huffman) and Neurology (Healy), Massachusetts General Hospital, Boston; The Methodology Center and Department of Human Development and Family Studies (Collins), Pennsylvania State University, University Park; and Division of Cardiology (Januzzi), Department of Medicine, Massachusetts General Hospital and Cardiometabolic Trials, Baim Institute for Clinical Research, Boston.
Abstract
OBJECTIVE: Despite the clear benefits of physical activity and related behaviors on prognosis, most patients experiencing an acute coronary syndrome (ACS) remain nonadherent to these behaviors. Deficits in positive psychological constructs (e.g., optimism) are linked to reduced participation in health behaviors, supporting the potential utility of a positive psychology (PP)-based intervention in post-ACS patients. Accordingly, we aimed to identify optimal components of a PP-based intervention to promote post-ACS physical activity. METHODS: As part of a multiphase optimization strategy, we completed a randomized factorial trial with eight conditions in 128 post-ACS patients to efficiently identify best-performing intervention components. All participants received a PP-based intervention, with conditions varying in duration (presence/absence of booster sessions), intensity (weekly/daily PP exercises), and content (PP alone or combined with motivational interviewing), allowing three concurrent comparisons within the trial. The study aims included assessments of the overall feasibility, acceptability, and impact of the intervention, along with the primary aim of determining which components were associated with objectively measured physical activity and self-reported health behavior adherence at 16 weeks, assessed using longitudinal models. RESULTS: The intervention was well accepted and associated with substantial improvements in behavioral and psychological outcomes. Booster sessions were associated with greater activity to a nearly significant degree (β = 8.58, 95% confidence interval = -0.49-17.65, effect size difference = .43, p = .064), motivational interviewing was associated with overall adherence (β = 0.95, 95% confidence interval = 0.02-1.87, effect size difference = .39, p = .044), and weekly exercise completion was generally superior to daily. CONCLUSIONS: These findings will enable optimization of the PP-based intervention in preparation for a well-powered controlled trial. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT02754895.
RCT Entities:
OBJECTIVE: Despite the clear benefits of physical activity and related behaviors on prognosis, most patients experiencing an acute coronary syndrome (ACS) remain nonadherent to these behaviors. Deficits in positive psychological constructs (e.g., optimism) are linked to reduced participation in health behaviors, supporting the potential utility of a positive psychology (PP)-based intervention in post-ACS patients. Accordingly, we aimed to identify optimal components of a PP-based intervention to promote post-ACS physical activity. METHODS: As part of a multiphase optimization strategy, we completed a randomized factorial trial with eight conditions in 128 post-ACS patients to efficiently identify best-performing intervention components. All participants received a PP-based intervention, with conditions varying in duration (presence/absence of booster sessions), intensity (weekly/daily PP exercises), and content (PP alone or combined with motivational interviewing), allowing three concurrent comparisons within the trial. The study aims included assessments of the overall feasibility, acceptability, and impact of the intervention, along with the primary aim of determining which components were associated with objectively measured physical activity and self-reported health behavior adherence at 16 weeks, assessed using longitudinal models. RESULTS: The intervention was well accepted and associated with substantial improvements in behavioral and psychological outcomes. Booster sessions were associated with greater activity to a nearly significant degree (β = 8.58, 95% confidence interval = -0.49-17.65, effect size difference = .43, p = .064), motivational interviewing was associated with overall adherence (β = 0.95, 95% confidence interval = 0.02-1.87, effect size difference = .39, p = .044), and weekly exercise completion was generally superior to daily. CONCLUSIONS: These findings will enable optimization of the PP-based intervention in preparation for a well-powered controlled trial. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT02754895.
Authors: Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner Journal: J Am Coll Cardiol Date: 2012-09-05 Impact factor: 24.094
Authors: Linda M Collins; Jessica B Trail; Kari C Kugler; Timothy B Baker; Megan E Piper; Robin J Mermelstein Journal: Transl Behav Med Date: 2014-09 Impact factor: 3.046
Authors: Jeff C Huffman; Christina M DuBois; Carol A Mastromauro; Shannon V Moore; Laura Suarez; Elyse R Park Journal: J Health Psychol Date: 2014-08-11
Authors: Ian M Kronish; Keith M Diaz; Jeff Goldsmith; Nathalie Moise; Joseph E Schwartz Journal: J Am Coll Cardiol Date: 2017-03-07 Impact factor: 24.094
Authors: Clara K Chow; Sanjit Jolly; Purnima Rao-Melacini; Keith A A Fox; Sonia S Anand; Salim Yusuf Journal: Circulation Date: 2010-02-01 Impact factor: 29.690
Authors: Michael F Scheier; Vicki S Helgeson; Richard Schulz; Suzanne Colvin; Sarah L Berga; Judy Knapp; Kristina Gerszten Journal: J Clin Oncol Date: 2007-11-12 Impact factor: 44.544
Authors: Christina M Dubois; Scott R Beach; Todd B Kashdan; Maren B Nyer; Elyse R Park; Christopher M Celano; Jeff C Huffman Journal: Psychosomatics Date: 2012 Jul-Aug Impact factor: 2.386
Authors: Jeff C Huffman; Carol A Mastromauro; Scott R Beach; Christopher M Celano; Christina M DuBois; Brian C Healy; Laura Suarez; Bruce L Rollman; James L Januzzi Journal: JAMA Intern Med Date: 2014-06 Impact factor: 21.873
Authors: Catherine N Marti; Vasiliki V Georgiopoulou; Grigorios Giamouzis; Robert T Cole; Anjan Deka; W H W Tang; Sandra B Dunbar; Andrew L Smith; Andreas P Kalogeropoulos; Javed Butler Journal: Congest Heart Fail Date: 2012-09-09
Authors: Laura D Kubzansky; Jeff C Huffman; Julia K Boehm; Rosalba Hernandez; Eric S Kim; Hayami K Koga; Emily H Feig; Donald M Lloyd-Jones; Martin E P Seligman; Darwin R Labarthe Journal: J Am Coll Cardiol Date: 2018-09-18 Impact factor: 24.094
Authors: Peter James; Eric S Kim; Laura D Kubzansky; Emily S Zevon; Claudia Trudel-Fitzgerald; Francine Grodstein Journal: Am J Prev Med Date: 2019-01 Impact factor: 5.043
Authors: Eric S Kim; Peter James; Emily S Zevon; Claudia Trudel-Fitzgerald; Laura D Kubzansky; Francine Grodstein Journal: Am J Epidemiol Date: 2019-06-01 Impact factor: 4.897
Authors: Christopher M Celano; Melanie E Freedman; Lauren E Harnedy; Elyse R Park; James L Januzzi; Brian C Healy; Jeff C Huffman Journal: J Psychosom Res Date: 2020-10-29 Impact factor: 3.006
Authors: Kirsti A Campbell; Brian C Healy; Christopher M Celano; Ariana Albanese; Rachel A Millstein; Jeff C Huffman Journal: J Psychosom Res Date: 2018-06-13 Impact factor: 3.006
Authors: Christopher M Celano; Melanie E Freedman; Eleanor E Beale; Federico Gomez-Bernal; Jeff C Huffman Journal: J Nerv Ment Dis Date: 2018-10 Impact factor: 2.254
Authors: Jeong Hwan Kim; Shabatun J Islam; Matthew L Topel; Yi-An Ko; Mahasin S Mujahid; Viola Vaccarino; Chang Liu; Mario Sims; Mohamed Mubasher; Charles D Searles; Sandra B Dunbar; Priscilla Pemu; Herman A Taylor; Arshed A Quyyumi; Peter Baltrus; Tené T Lewis Journal: Circ Cardiovasc Qual Outcomes Date: 2020-10-07
Authors: Jeff C Huffman; Rachel A Millstein; Christopher M Celano; Brian C Healy; Elyse R Park; Linda M Collins Journal: Ann Behav Med Date: 2020-02-21